Clearside Biomedical Receivables

Clearside Biomedical (CLSD) currently reports a receivables of $270K as of September 2025. That compares with $790K in the prior-year period — down 66.2% year over year. Use the charts on this page to explore Clearside Biomedical's receivables history and peer comparisons.

Clearside Biomedical's receivables decreased from $790K to $270K — a 66.2% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clearside Biomedical reported $270K in receivables as of September 2025. That compares with $790K in the prior-year period — down 66.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $270K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clearside Biomedical, and consider following CLSD for alerts when major investors trade the stock.

Clearside Biomedical is classified in the Healthcare sector. On receivables, it currently shows $270K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLSD with unrelated industries.